CHARACTERIZING and MANIPULATING BIOLOGICAL INTERACTIONS of VIRUSES by NEETU MEHEK GULATI Submitted in Partial Fulfillment Of
Total Page:16
File Type:pdf, Size:1020Kb
CHARACTERIZING AND MANIPULATING BIOLOGICAL INTERACTIONS OF VIRUSES by NEETU MEHEK GULATI Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy Dissertation Advisors: Dr. Phoebe L. Stewart and Dr. Nicole F. Steinmetz Department of Pharmacology CASE WESTERN RESERVE UNIVERSITY January 2018 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the thesis/dissertation of Neetu Mehek Gulati candidate for the Doctor of Philosophy degree*. (signed) Vera Moiseenkova-Bell (chair of the committee) Phoebe L. Stewart Nicole F. Steinmetz Derek J. Taylor Jun Qin Vivien C. Yee (date) September 8, 2017 *We also certify that written approval has been obtained for any proprietary material contained therein. Table of Contents List of Tables ..................................................................................................... vii List of Figures .................................................................................................. viii Acknowledgements ........................................................................................... xi List of Abbreviations ....................................................................................... xiv Abstract ............................................................................................................ xxi Chapter 1: Introduction ...................................................................................... 1 1.1 Viruses – for good and bad ................................................................. 1 1.2 Bioinspired shielding strategies for nanotechnology applications . 2 1.2.1 Abstract ....................................................................................... 2 1.2.2 Introduction .................................................................................. 3 1.2.3 PEG and other synthetic polymeric shielding strategies .............. 4 1.2.4 Bio-inspired shielding strategies .................................................. 9 1.2.5 Beyond shielding – Immune editing ........................................... 21 1.2.6 Conclusions ............................................................................... 22 1.3 Tobacco mosaic virus as a nanotechnology platform .................... 25 1.3.1 Tobacco mosaic virus infection and production ......................... 25 1.3.2 Tobacco mosaic virus structure ................................................. 25 1.3.3 Tobacco mosaic virus nanoparticles .......................................... 28 1.4 Human papillomavirus infection and neutralization ........................ 28 1.4.1 Human papillomavirus and cancer ............................................ 28 1.4.2 Human papillomavirus vaccines ................................................ 29 i 1.4.3 Human papillomavirus structure ................................................ 30 1.4.4 Human papillomavirus cell entry mechanism and infection pathway .............................................................................................. 35 1.4.5 Human papillomavirus and human alpha-defensin 5 ................. 37 1.5 Aims of dissertation ........................................................................... 40 Chapter 2: Structural characterization of SA-TMV ........................................ 41 2.1 Abstract ............................................................................................... 41 2.2 Introduction ......................................................................................... 42 2.3 Materials and Methods ....................................................................... 45 2.3.1 Virus propagation and purification ............................................. 45 2.3.2 TMV sCy5 labeling .................................................................... 45 2.3.3 TMV conjugation ........................................................................ 46 2.3.4 SDS-PAGE analysis .................................................................. 47 2.3.5 Western blot analysis ................................................................ 47 2.3.6 Immuno-dot blots ....................................................................... 48 2.3.7 Negative stain transmission electron microscopy ...................... 48 2.3.8 Cryo-electron microscopy and tomography ............................... 48 2.3.9 Subtomogram averaging of SA .................................................. 49 2.3.10 Subtomogram averaging of SA-TMV segment ........................ 50 2.3.11 Analysis of volume coverage ................................................... 50 2.3.12 Analysis of surface coverage ................................................... 51 2.4 Results and Discussion ..................................................................... 51 2.4.1 Particle preparation ................................................................... 51 ii 2.4.2 Imaging and processing of naked and SA-coated particles ....... 57 2.4.3 Quantification of TMV coverage ................................................ 66 2.5 Conclusions ........................................................................................ 69 2.6 Acknowledgements ............................................................................ 70 2.7 Supplementary information ............................................................... 71 Chapter 3: Immune recognition of SA-TMV .................................................... 72 3.1 Abstract ............................................................................................... 72 3.2 Introduction ......................................................................................... 73 3.3 Materials and Methods ....................................................................... 76 3.3.1 Virus propagation and purification ............................................. 76 3.3.2 TMV sCy5 labeling .................................................................... 77 3.3.3 TMV external conjugation .......................................................... 77 3.3.4 SDS-PAGE analysis .................................................................. 78 3.3.5 Western blot analysis ................................................................ 79 3.3.6 Negative stain transmission electron microscopy ...................... 79 3.3.7 Dot blots .................................................................................... 80 3.3.8 In vivo studies and ELISA assays .............................................. 80 3.3.9 Confocal microscopy ................................................................. 81 3.3.10 Lysosomal extraction experiments ........................................... 82 3.4 Results and Discussion ..................................................................... 83 3.4.1 Synthesis and characterization of SA-TMV constructs .............. 83 3.4.2 Effects of SA coverage and linker length on shielding TMV ....... 92 iii 3.4.3 Antibody response to multiple administrations of SA-TMV constructs ........................................................................................... 97 3.4.4 Trafficking of SA-TMV nanoparticles upon cell uptake ............ 103 3.4.5 SA-TMV cleavage and degradation in the lysosome ............... 109 3.5 Conclusions ...................................................................................... 112 3.6 Acknowledgements .......................................................................... 113 Chapter 4: cryoEM of HPV PsV with HD5 ..................................................... 114 4.1 Introduction ....................................................................................... 114 4.2 Materials and Methods ..................................................................... 119 4.2.1 Protein disorder prediction and modeling ................................. 119 4.2.2 HPV16 pseudovirus production ................................................119 4.2.3 CryoEM grid preparation ..........................................................119 4.2.4 CryoEM imaging and data collection ....................................... 120 4.2.5 Particle picking and CTF correction ......................................... 120 4.2.6 3D structure determination and filtering ................................... 120 4.3 Results and Discussion ................................................................... 121 4.3.1 Sub-nanometer resolution structures of HPV16 and HPV16+HD5 by RELION ....................................................................................... 121 4.3.2 Gaussian filtered HPV16 and HPV16+HD5 maps reveal additional density in the HD5 structure ............................................. 126 4.4 Conclusions ...................................................................................... 135 Chapter 5: Conclusions and Future Directions ........................................... 137 5.1 Scope of work ................................................................................... 137 iv 5.2 Viruses in nanomedicine: evading immune recognition of TMV nanoparticles by stealth-camouflage with SA ..................................... 138 5.2.1 Tobacco mosaic virus as a nanocarrier for drug delivery applications ...................................................................................... 140 5.2.2 Novel SA self-camouflage platform .......................................... 143 5.2.3 Considerations beyond SA-TMV ............................................. 149 5.3. Viruses in human disease: